These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25279555)

  • 21. A prospective before-and-after trial of an educational intervention about pharmaceutical marketing.
    Agrawal S; Saluja I; Kaczorowski J
    Acad Med; 2004 Nov; 79(11):1046-50. PubMed ID: 15504769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in medical students' exposure to and attitudes about drug company interactions from 2003 to 2012: a multi-institutional follow-up survey.
    Sierles FS; Kessler KH; Mintz M; Beck G; Starr S; Lynn DJ; Chao J; Cleary LM; Shore W; Stengel TL; Brodkey AC
    Acad Med; 2015 Aug; 90(8):1137-46. PubMed ID: 25785675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical Schools' Industry Interaction Policies Not Associated With Trainees' Self-Reported Behavior as Residents: Results of a National Survey.
    Yeh JS; Austad KE; Franklin JM; Chimonas S; Campbell EG; Avorn J; Kesselheim AS
    J Grad Med Educ; 2015 Dec; 7(4):595-602. PubMed ID: 26692972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychiatric resident and faculty views on and interactions with the pharmaceutical industry.
    Misra S; Ganzini L; Keepers G
    Acad Psychiatry; 2010; 34(2):102-8. PubMed ID: 20224017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives?
    Alssageer MA; Kowalski SR
    Pan Afr Med J; 2013; 14():132. PubMed ID: 23734277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Frequency and type of gifts given by pharmaceutical industry to cardiology residents].
    Moubarak G; Martins RP; Zuily S; Mechulan A; Guiot A
    Presse Med; 2010 Sep; 39(9):e197-204. PubMed ID: 20399070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
    Fickweiler F; Fickweiler W; Urbach E
    BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical students' attitudes toward interactions with the pharmaceutical industry: a national survey in Japan.
    Saito S; Maeno T; Miyata Y; Maeno T
    BMC Med Educ; 2018 Dec; 18(1):286. PubMed ID: 30509273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knowledge, beliefs and attitudes of physicians in low and middle-income countries regarding interacting with pharmaceutical companies: a systematic review.
    Lotfi T; Morsi RZ; Rajabbik MH; Alkhaled L; Kahale L; Nass H; Brax H; Fadlallah R; Akl EA
    BMC Health Serv Res; 2016 Feb; 16():57. PubMed ID: 26883210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicians' attitudes towards interaction with the pharmaceutical industry.
    Alosaimi FD; Al Kaabba A; Qadi M; Albahlal A; Alabdulkarim Y; Alabduljabbar M; Alqahtani F
    East Mediterr Health J; 2015 Feb; 20(12):812-9. PubMed ID: 25664520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exposure of medical students to pharmaceutical marketing in primary care settings: frequent and influential.
    Sarikaya O; Civaner M; Vatansever K
    Adv Health Sci Educ Theory Pract; 2009 Dec; 14(5):713-24. PubMed ID: 19184498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical representatives and emergency medicine residents: a national survey.
    Reeder M; Dougherty J; White LJ
    Ann Emerg Med; 1993 Oct; 22(10):1593-6. PubMed ID: 8214843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives.
    Hopper JA; Speece MW; Musial JL
    J Gen Intern Med; 1997 Oct; 12(10):639-42. PubMed ID: 9346461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.
    Halperin EC; Hutchison P; Barrier RC
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1477-83. PubMed ID: 15275735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical students' attitudes to and contact with the pharmaceutical industry: a survey at eight German university hospitals.
    Lieb K; Koch C
    Dtsch Arztebl Int; 2013 Sep; 110(35-36):584-90. PubMed ID: 24078838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proposed model for interaction between residents and residency training programs, and pharmaceutical industry.
    Razack S; Arbour L; Hutcheon R
    Ann R Coll Physicians Surg Can; 1999 Mar; 32(2):93-6. PubMed ID: 12378718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing stakeholder opinion on relations between cancer patient groups and pharmaceutical companies in Europe.
    Leto di Priolo S; Fehervary A; Riggins P; Redmond K
    Patient; 2012; 5(2):127-39. PubMed ID: 22299759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical students' exposure to and attitudes about drug company interactions: a national survey.
    Sierles FS; Brodkey AC; Cleary LM; McCurdy FA; Mintz M; Frank J; Lynn DJ; Chao J; Morgenstern BZ; Shore W; Woodard JL
    JAMA; 2005 Sep; 294(9):1034-42. PubMed ID: 16145023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physician attitudes toward industry: a view across the specialties.
    Korenstein D; Keyhani S; Ross JS
    Arch Surg; 2010 Jun; 145(6):570-7. PubMed ID: 20566978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.